Palantir

Bull v Bear: Who’s right about Palantir?

Equities 7 minutes to read
Neil Wilson
Neil Wilson

Investor Content Strategist

Note: This is marketing material. This article is not investment advice, capital is at risk.

Key Points

  • Palantir stock has been having a rough time as the once buoyant AI stock trades down by around –21% this year.
  • Investors are worried about AI start-up Anthropic, which has been releasing a series of new models, disrupting Palantir.
  • Famed short seller Michael Burry said Anthropic is “eating Palantir’s lunch” as he confirmed he remains short the stock.
  • Shares of Palantir slid over 13% last week despite a bounce on Friday and extended on Monday following a supportive message from President Trump. 

“Big Short” investor Michael Burry says he’s still bearish on defence tech company Palantir Technologies, posting on Substack that he’s still holding long-dated put options on stock. 

“I now own the June 17 2027 Strike Price 50 Puts and the Decembers 19, 2026 Strike Price 100 Puts. I am not selling these today,” he wrote. (read about PLTR options strategies)

His comments came after President Trump gave the stock lift with a post on his Truth Social account on Friday. “Palantir Technologies (PLTR) has proven to have great warfighting capabilities and equipment,” he posted. “Just ask our enemies!!!”

Nevertheless, PLTR suffered a weekly drop of more than 13%, before rallying Monday, taking its YTD decline to around 21%. Palantir closed Monday's session at $132.37.

“Trump’s post rallied the stock after the stock had fallen 18% the last three days. The stock may catch a wind here. It has been selling off with software stocks. As mentioned, I continue to hold the puts, as I believe the fundamental value of this company is well under $50/share,” added Burry, who first disclosed bearish bets against Palantir – along with Nvidia – in the autumn of 2025.

It’s all about Anthropic

Burry believes Anthropic “is eating Palantir’s lunch”, as he wrote last week in a now-deleted post on X. “Anthropic went from $9B to $30B in months, it took $PLTR 20 years to get to $5 Billion,” he added.

Almost one in three US businesses paid for Anthropic tools last month, according to data from payments group Ramp,amid surging interest in its suite of Claude Code products and assorted plug-ins that have rocked a large part of the software sector this year.

Anthropic’s rapid pace of growth continued last month, growing from 24.4% to 30.6% of businesses. OpenAI still leads with 35.2% of businesses at this pace, “Anthropic will overtake OpenAI within the next two months”, according to Ramp.

Last week Anthropic announced that will limit the rollout of its Claude Mythos tool to a select group of companies as part of new cybersecurity initiative called Project Glasswing. The reason for the limited launch is the risks of the tool being used by bad actors. Claude Mythos "has already found thousands of high-severity vulnerabilities, including some in every major operating system and web browser."

This sent fresh shockwaves through some of the exposed software and cybersecurity stocks last week. 

For Palantir, the risk is double-edged as it not only faces competition from Anthropic but it also uses Claude in its tools. Palantir CEO Alex Karp has vowed to “phase out” Anthropic’smodels after the Pentagon black-listed Anthropic for voicing concerns about the use of its tools for autonomous weapons and surveillance.

Zero sum?

The question of whether the rise of Anthropic (and other AI companies for that matter) necessarily threatens Palantir (and other software stocks for that matter). This is the whole AI is killing software narrative that has plunged a host of software stocks this year.

But according to Wedbush, Anthropic’s growth does not come at the expense of PLTR's business as the company continues to accelerate both its US commercial and government businesses - US commercial revenues +137% y/y and US government +66% y/y, for instance. Palantir reported Q4 2025 revenue of $1.407 billion, up 70% year on year and up 19% quarter on quarter, also revenue growth continues to accelerate with the y/y growth rate almost doubling from +36% in Q4 2024.

The idea that Anthropic is eating Palantir’s lunch is the is the “wrong take and fictional narrative”, says Wedbush analyst Dan Ives.

“Palantir is at the epicenter of leaders in the AI Revolution while its AIP product moat remains unmatched in our view," he argued "The data-driven moat by Palantir is around the data and its ontology…this is NOT being disrupted by Claude…if anything, it's accelerated on the enterprise."

pltr analysts 130426
Source: Saxo/FactSet

This material is marketing content and should not be regarded as investment advice. Trading financial instruments carries risks and historic performance is not a guarantee of future results.
The instrument(s) referenced in this content may be issued by a partner, from whom Saxo receives promotional fees, payment or retrocessions. While Saxo may receive compensation from these partnerships, all content is created with the aim of providing clients with valuable information and options.

 

Outrageous Predictions 2026

01 /

  • Executive Summary: Outrageous Predictions 2026

    Outrageous Predictions

    Executive Summary: Outrageous Predictions 2026

    Saxo Group

    Read Saxo's Outrageous Predictions for 2026, our latest batch of low probability, but high impact ev...
  • A Fortune 500 company names an AI model as CEO

    Outrageous Predictions

    A Fortune 500 company names an AI model as CEO

    Charu Chanana

    Chief Investment Strategist

    Can AI be trusted to take over in the boardroom? With the right algorithms and balanced human oversi...
  • Dollar dominance challenged by Beijing’s golden yuan

    Outrageous Predictions

    Dollar dominance challenged by Beijing’s golden yuan

    Charu Chanana

    Chief Investment Strategist

    Beijing does an end-run around the US dollar, setting up a framework for settling trade in a neutral...
  • Obesity drugs for everyone – even for pets

    Outrageous Predictions

    Obesity drugs for everyone – even for pets

    Jacob Falkencrone

    Global Head of Investment Strategy

    The availability of GLP-1 drugs in pill form makes them ubiquitous, shrinking waistlines, even for p...
  • Dumb AI triggers trillion-dollar clean-up

    Outrageous Predictions

    Dumb AI triggers trillion-dollar clean-up

    Jacob Falkencrone

    Global Head of Investment Strategy

    Agentic AI systems are deployed across all sectors, and after a solid start, mistakes trigger a tril...
  • Quantum leap Q-Day arrives early, crashing crypto and destabilizing world finance

    Outrageous Predictions

    Quantum leap Q-Day arrives early, crashing crypto and destabilizing world finance

    Neil Wilson

    Investor Content Strategist

    A quantum computer cracks today’s digital security, bringing enough chaos with it that Bitcoin crash...
  • SpaceX announces an IPO, supercharging extraterrestrial markets

    Outrageous Predictions

    SpaceX announces an IPO, supercharging extraterrestrial markets

    John J. Hardy

    Global Head of Macro Strategy

    Financial markets go into orbit, to the moon and beyond as SpaceX expands rocket launches by orders-...
  • Taylor Swift-Kelce wedding spikes global growth

    Outrageous Predictions

    Taylor Swift-Kelce wedding spikes global growth

    John J. Hardy

    Global Head of Macro Strategy

    Next year’s most anticipated wedding inspires Gen Z to drop the doomscrolling and dial up the real w...
  • Britain’s Great EU Backdoor Return

    Outrageous Predictions

    Britain’s Great EU Backdoor Return

    Neil Wilson

    Investor Content Strategist

    Faced with rolling fiscal, economic, trade and political crises the UK government sneaks back into t...
  • Despite concerns, U.S. 2026 mid-term elections proceed smoothly

    Outrageous Predictions

    Despite concerns, U.S. 2026 mid-term elections proceed smoothly

    John J. Hardy

    Global Head of Macro Strategy

    In spite of outstanding threats to the American democratic process, the US midterms come and go cord...

This content is marketing material. 

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Market Ltd. (SCML) provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice or a recommendation.

SCML content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

SCML partners with companies that provide compensation for promotional activities conducted on its platform. Some partners also pay retrocessions contingent on clients investing in products from those partners. 

While SCML receives compensation from these partnerships, all educational and research content remains focused on providing information to clients.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. SCML does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992